Obstetrics & Gynecology Doctors in Sidney, MT Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Dr. Robert E Hardy, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 216 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2577    Fax: 406-488-2125

Dr. Malua Tambi Iya, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 214 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2100

Dr. Shari Jean Twigg, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 214 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2577

Lisa Rene Ross, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 214 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2100    Fax: 406-488-2125

News Archive

A view from the field: How Medicare is playing in congressional, Senate races

From Texas to Connecticut, members of Congress and their challengers are pressing their views on the federal health program for seniors.

State roundup: Rules would ban collections in nonprofit ERs

The U.S. Department of Treasury released proposed regulations Monday that would ban debt collection activities in the emergency rooms of non-profit hospitals. The proposed restriction comes in the wake of a lawsuit by Minnesota's attorney general alleging Fairview Health Systems former contractor, Accretive Health hit up patients in emergency rooms for payment before treatment. The Treasury Department has proposed adding regulations to a part of the federal health care law to protect patients from abusive collection practices.

Role of gene identified in development of tumours in children

Medical researchers from Children's Cancer Institute Australia for Medical Research (CCIA) have made significant progress in understanding tumour initiation in the aggressive, debilitating childhood cancer, neuroblastoma

Sanofi announces new results from alemtuzumab-Rebif comparative CARE-MS I trial

Sanofi and its subsidiary Genzyme announced today new results from the CARE-MS I trial, the first of two randomized, Phase III clinical trials comparing the investigational drug alemtuzumab to Rebif (high dose subcutaneous interferon beta-1a) in patients with relapsing-remitting multiple sclerosis.

SAMHSA awards $12.2M in grants to train behavioral health care providers

Five minority fellowship program grants are being awarded by the Substance Abuse and Mental Health Services Administration for a total of up to $12.2 million. These three-year grants will be used to train a new wave of behavioral health care providers. The program focuses on increasing the number of culturally competent behavioral health professionals available in underserved racially and ethnically diverse communities.

Read more Medical News

› Verified 6 days ago